IPSC Bear Put Spread Strategy
IPSC (Century Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Century Therapeutics, Inc. is a biotechnology company dedicated to pioneering allogeneic cell therapies for a range of cancers, specifically solid tumors and hematological malignancies. The firm's foremost clinical program is CNTY-101, an allogeneic, induced pluripotent stem cell (iPSC)-derived CAR-iNK cell therapy. This therapy is specifically designed to target CD19 in patients with B-cell lymphoma that has relapsed or proven refractory to previous treatments. In addition to its lead candidate, the company's robust pipeline features several other therapeutic assets: CNTY-103: A CAR-iNK candidate aimed at CD133 + EGFR for recurrent glioblastoma. CNTY-102: A CAR-iT therapy targeting CD19 + CD79b, intended for relapsed or refractory B-cell lymphoma and other B-cell cancers. CNTY-104: A multi-specific CAR-iT or CAR-iNK candidate in development for acute myeloid leukemia.
IPSC (Century Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $200.8M, a beta of 1.57 versus the broader market, a 52-week range of 0.435-3.04, average daily share volume of 979K, a public-listing history dating back to 2021, approximately 140 full-time employees. These structural characteristics shape how IPSC stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.57 indicates IPSC has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a bear put spread on IPSC?
A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width.
Current IPSC snapshot
As of June 29, 2026, spot at $2.41, ATM IV 343.80%, IV rank 67.78%, expected move 98.56%. The bear put spread on IPSC below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this bear put spread structure on IPSC specifically: IPSC IV at 343.80% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 98.56% (roughly $2.38 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IPSC expiries trade a higher absolute premium for lower per-day decay. Position sizing on IPSC should anchor to the underlying notional of $2.41 per share and to the trader's directional view on IPSC stock.
IPSC bear put spread setup
The IPSC bear put spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IPSC near $2.41, the first option leg uses a $2.41 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IPSC chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IPSC shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $2.41 | N/A |
| Sell 1 | Put | $2.29 | N/A |
IPSC bear put spread risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit.
IPSC bear put spread payoff curve
Modeled P&L at expiration across a range of underlying prices for the bear put spread on IPSC. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use bear put spread on IPSC
Bear put spreads on IPSC reduce the cost of a bearish IPSC stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
IPSC thesis for this bear put spread
The market-implied 1-standard-deviation range for IPSC extends from approximately $0.03 on the downside to $4.79 on the upside. A IPSC bear put spread caps both the risk and the reward of a bearish position; relative to an outright long put on IPSC, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current IPSC IV rank near 67.78% is mid-range against its 1-year distribution, so the IV signal is neutral; the bear put spread thesis on IPSC should anchor more to the directional view and the expected-move geometry. As a Healthcare name, IPSC options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IPSC-specific events.
IPSC bear put spread positions are structurally moderately bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IPSC positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IPSC alongside the broader basket even when IPSC-specific fundamentals are unchanged. Long-premium structures like a bear put spread on IPSC are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current IPSC chain quotes before placing a trade.
Frequently asked questions
- What is a bear put spread on IPSC?
- A bear put spread on IPSC is the bear put spread strategy applied to IPSC (stock). The strategy is structurally moderately bearish: A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width. With IPSC stock trading near $2.41, the strikes shown on this page are snapped to the nearest listed IPSC chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IPSC bear put spread max profit and max loss calculated?
- Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit. For the IPSC bear put spread priced from the end-of-day chain at a 30-day expiry (ATM IV 343.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IPSC bear put spread?
- The breakeven for the IPSC bear put spread priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IPSC market-implied 1-standard-deviation expected move is approximately 98.56%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a bear put spread on IPSC?
- Bear put spreads on IPSC reduce the cost of a bearish IPSC stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
- How does current IPSC implied volatility affect this bear put spread?
- IPSC ATM IV is at 343.80% with IV rank near 67.78%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.